Stay Updated:
Discover the Latest News & Events!

CBmed Celebrates 10 Years of Revolutionizing Precision Medicine

CBmed celebrated its 10th anniversary on September 23, 2024, marking a decade of advancements in precision medicine and biomarker research, while reflecting on its growth into a leader in personalized healthcare through strategic collaborations and cutting-edge innovations.

microONE Project Featured in Ö1 Podcast on Microplastics

CBmed recently featured on the Ö1 podcast, discussing the health impacts of microplastics and showcasing the vital work of the microONE project in addressing this global issue.

MMag. Barbara Eibinger-Miedl Visits New Labs at ZWT1

Styrian State Minister MMag. Barbara Eibinger-Miedl visited CBmed’s new facilities, highlighting the impactful collaboration with Boehringer Ingelheim that is advancing cancer research and creating job opportunities in Styria.

Accelerating Cancer Drug Development: Innovations at CBmed

In a Der Standard article, CBmed is highlighted for its innovative strategies in cancer drug development, focusing on the integration of laboratory research and bioinformatics to accelerate the discovery of personalized therapies.

Probiotics Show Promise for COVID-19 Recovery

A study by CBmed and the Medical University of Graz suggests probiotics could accelerate COVID-19 recovery by restoring gut health.

CBmed and Boehringer Ingelheim’s Strategic Partnership to Transform Cancer Care

Boehringer Ingelheim and CBmed have announced a strategic partnership to accelerate the development of innovative cancer therapies through advanced translational medicine approaches.

CBmed Joins ATTRACT to Transform Glioblastoma Care

CBmed announces its participation in the groundbreaking ATTRACT project, aimed at revolutionizing glioblastoma treatment through personalized therapies and innovative drug screening.